Biotechnologies Firm to Offer Opportunities to Develop Life-Saving Technology

Fujifilm Diosynth Biotechnologies will expand its campus in College Station-Bryan with an additional commercial manufacturing facility. Fujifilm Diosynth Biotechnologies, a partnership between Fujifilm Corporation and Mitsubishi Corporation, is a contract development and manufacturing organization with experience in the development and manufacture of recombinant biopharmaceuticals and viral gene therapies.

“The biopharmaceutical industry’s need for manufacturing capacity continues to grow rapidly,” said Gerry Farrell, chief operating officer for Fujifilm Diosynth Biotechnologies Texas. “Committed to being a partner for life for our customers, we will continue to invest in the right technology and talent to support our partners in bringing to market these life-impacting medicines.”

The project is expected to create approximately 150 new jobs and approximately $300 million in capital investment from Fujifilm Corporation. A Texas Enterprise Fund grant of $1.5 million has been extended to Fujifilm Diosynth Biotechnologies.

“Fujifilm Diosynth Biotechnologies’ expansion is wonderful news for the hardworking people of College Station-Bryan, and it will bring more opportunities for Texans to develop life-saving technology and treatment,” said Gov. Greg Abbott. “The biotechnology industry is growing at a tremendous rate in Texas, and I thank Fujifilm Diosynth Biotechnologies for their continued investment in the Brazos Valley that will keep the Lone Star State competitive in this field.”